Evidence map›Paper›PMID 37707855›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2023

An Overview of Miami CDEIPI and a Showcase of Team Science and Cutting-Edge Research Driven by Students.

Suresh Pallikkuth, Mickensone Andre, Florida Owens, Sheldon Davis, Jennifer Chavez, Christian McDonald, Andrea Raymond, Nazira El-Hage, Adam Carrico, Noula Shembade and 2 more

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Suresh PallikkuthDepartment of Microbiology and Immunology, Center for AIDS Research, University of Miami School of Medicine, Miami, FL.
Mickensone AndreDepartment of Immunology and Nanomedicine, Herbert Wertheim College of Medicine, Miami, FL; and.
Florida OwensDepartment of Immunology and Nanomedicine, Herbert Wertheim College of Medicine, Miami, FL; and.
Sheldon DavisDepartment of Microbiology and Immunology, Center for AIDS Research, University of Miami School of Medicine, Miami, FL.
Jennifer ChavezDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL.
Christian McDonaldDepartment of Microbiology and Immunology, Center for AIDS Research, University of Miami School of Medicine, Miami, FL.
Andrea RaymondDepartment of Immunology and Nanomedicine, Herbert Wertheim College of Medicine, Miami, FL; and.
Nazira El-HageDepartment of Immunology and Nanomedicine, Herbert Wertheim College of Medicine, Miami, FL; and.
Adam CarricoDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL.
Noula ShembadeDepartment of Microbiology and Immunology, Center for AIDS Research, University of Miami School of Medicine, Miami, FL.
Zhibin ChenDepartment of Microbiology and Immunology, Center for AIDS Research, University of Miami School of Medicine, Miami, FL.
Savita PahwaDepartment of Microbiology and Immunology, Center for AIDS Research, University of Miami School of Medicine, Miami, FL.ORCID 0000-0002-4470-4216

Funding

University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ALLAN E RODRIGUEZ · 2007 to 2026
$33.8M
SWG 2: Cure Research Scientific Working GroupP30AI117970 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI Italo Mocchetti · 2015 to 2026
$29.6M
Predoctoral Training in Translational ImmunologyT32AI162624 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Thomas R Malek · 2022 to 2026
$894k
NIAID NIH HHS P30 AI073961NIAID NIH HHS P30 AI117970NIAID NIH HHS T32 AI162624
6 · The paper itself

Abstract

backgroundThe Miami-CFAR Diversity, Equity & Inclusion Pathway Initiative (Miami CDEIPI) is designed to promote a diverse scientific workforce that reflects the communities at the highest risk of HIV in South Florida. SETTING AND

methodsThe focus of the Miami CDEIPI is to help train the next generation of Underrepresented Minorities (URM) and Black, Indigenous, People of Color (BIPOC) in HIV/AIDS-related research through a team science experience. The Miami CDEIPI objectives are to facilitate the interaction of URM/BIPOC students with the network of CFAR-affiliated investigators and to enable these students to access the cutting-edge technologies at the Miami-CFAR and the Sylvester Comprehensive Cancer Center and other resources at the University of Miami.

resultsFive URM/BIPOC students supported by the program in year 1 have been carrying out projects in collaboration with mentors at their parent institution and Miami-CFAR investigators. The students used the state-of-the-art laboratories and core facilities. They began their research with a proposal designed to integrate the cutting-edge technologies now available to them. Their training included participation in Miami-CFAR-sponsored activities such as seminars, an annual conference, and a national HIV workshop. Candidates in the Miami CDEIPI are in the process of developing their research proposals, integrating cutting-edge technologies into their doctoral dissertation research. Their projects are now in the completion phase.

conclusionsThe Miami CDEIPI focuses its resources on one of the conspicuous gaps in the career paths of URM/BIPOC researchers-the dearth of leading URM/BIPOC scientists in the field. The Miami CDEIPI provides a professional network that supports the participation of URM/BIPOC trainees in innovative research and career skill training.

Indexed as

Acquired Immunodeficiency SyndromeHIV InfectionsFloridaHumansInterdisciplinary ResearchStudents

Identifiers

PMID37707855
PMCPMC11267984

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.